Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

Designing optimal (neo)adjuvant therapy is a crucial aspect of the treatment of non-small-cell lung carcinoma (NSCLC). Standard methods of chemotherapy, radiotherapy, and immunotherapy represent effective strategies for treatment. However, in some cases with high metastatic activity and high levels...

Full description

Bibliographic Details
Main Authors: Zdeněk Kejík, Robert Kaplánek, Petr Dytrych, Michal Masařík, Kateřina Veselá, Nikita Abramenko, David Hoskovec, Martina Vašáková, Jarmila Králová, Pavel Martásek, Milan Jakubek
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Pharmaceutics
Subjects:
CTCs
NSCLCs
metastasis suppression
curcumin
flavonoids
Online Access:https://www.mdpi.com/1999-4923/13/11/1879

Internet

https://www.mdpi.com/1999-4923/13/11/1879

Similar Items